Amedeo's Top 20

Amedeo Smart

Independent Medical Education

03 November 2014

Multidisciplinary Journal Club

  1. Lawitz E, Poordad F, Brainard DM, Hyland RH, et al.
    Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis.
    Hepatology 2014.

  1. Tebas P, Stein D, Tang WW, Frank I, et al.
    Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.
    N Engl J Med 2014;370:901-10.

  2. Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, et al.
    Combination long-acting beta-agonists and inhaled corticosteroids compared with long-acting beta-agonists alone in older adults with chronic obstructive pulmonary disease.
    JAMA 2014;312:1114-21.

  3. Liu S, Watcha D, Holodniy M, Goldhaber-Fiebert JD, et al.
    Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in u.s. Incarcerated populations: a cost-effectiveness analysis.
    Ann Intern Med 2014;161:546-53.

  4. Jindani A, Harrison TS, Nunn AJ, Phillips PP, et al.
    High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.
    N Engl J Med 2014;371:1599-608.

  1. Loupakis F, Cremolini C, Masi G, Lonardi S, et al.
    Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
    N Engl J Med 2014;371:1609-18.

  2. Merle CS, Fielding K, Sow OB, Gninafon M, et al.
    A four-month gatifloxacin-containing regimen for treating tuberculosis.
    N Engl J Med 2014;371:1588-98.

  3. Lohrmann F , Dijkman R, Stertz S, Thiel V, et al.
    Emergence of a C-terminal seven amino acid elongation of NS1 around 1950 conferred a minor growth advantage to former seasonal influenza A viruses.
    J Virol 2013.

  4. Wang X, Ren J, Gao Q, Hu Z, et al.
    Hepatitis A virus and the origins of picornaviruses.
    Nature 2014.

  5. Rodrigo GJ, Castro-Rodriguez JA.
    Chest 2014.

  1. Sjoblom J, Muhrbeck J, Witt N, Alam M, et al.
    Evolution of Left Ventricular Ejection Fraction After Acute Myocardial Infarction: Implications for Implantable Defibrillator Eligibility.
    Circulation 2014.

  2. Mayer L , Sandborn WJ, Stepanov Y, Geboes K, et al.
    Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study.
    Gut 2013.

  3. Berg AT, Rychlik K, Levy SR, Testa FM, et al.
    Complete remission of childhood-onset epilepsy: stability and prediction over two decades.
    Brain 2014.

  4. Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME, et al.
    Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.
    JAMA 2014;312:1552-64.

  5. Zoungas S, Chalmers J, Neal B, Billot L, et al.
    Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes.
    N Engl J Med 2014.

  1. Doyle LW, Anderson PJ, Haslam R, Lee KJ, et al.
    School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
    JAMA 2014;312:1105-13.

  2. Ventetuolo CE, Gabler NB, Fritz JS, Smith KA, et al.
    Are Hemodynamics Surrogate Endpoints in Pulmonary Arterial Hypertension?
    Circulation 2014.

  3. Yin X , Lu G, Guo W, Qi T, et al.
    Identification of equine influenza virus infection in Asian wild horses (Equus przewalskii).
    Arch Virol 2013.

  4. Sands BE, Feagan BG, Rutgeerts P, Colombel JF, et al.
    Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
    Gastroenterology 2014;147:618-627.e3.

  5. Prideaux L , Kang S, Wagner J, Buckley M, et al.
    Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease.
    Inflamm Bowel Dis 2013;19:2906-18.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016